• Residual tumor volume and survival after CCNU/TMZ in GBM
    Nov 24 2024

    Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.

    Show more Show less
    13 mins
  • Alterations in RNA splicing between meningioma DNA methylation groups
    Nov 8 2024

    Dr. Evan Noch interviews Drs. Nathan Leclair, David Raleigh and Olga Anczukow about their recent manuscript entitled: "RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation groups", published online in Neuro-Oncology in August 2024.

    Show more Show less
    34 mins
  • The immune landscape of IDH mutant and IDHwt glioma
    Oct 25 2024

    Dr. Evan Noch interviews Drs. Pravesh Gupta and Krishna Bhat about their recent manuscript entitled "Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas", published online in Neuro-Oncology in August 2024

    Read Paper

    Show more Show less
    33 mins
  • Equity-driven applications of AI in neuro-oncology
    Oct 9 2024

    Dr. Iyad Alnahhas interviews Dr. Mulki Mehari about her and her team's recent manuscript entitled: "Enhancing neuro-oncology care through equity-driven applications of artificial intelligence", published online in Neuro-Oncology in August 2024.

    Show more Show less
    23 mins
  • IDH mutant glioma across age groups
    Sep 20 2024

    Dr. Maya Graham interviews Drs. Mary Jane Lim-Fat and Kee Kiat Yeo about their recent manuscript entitled "A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients", published online in Neuro-Oncology in July 2024.

    Link: https://doi.org/10.1093/neuonc/noae142

    Show more Show less
    35 mins
  • Contemporary molecular prognostic signatures in glioma
    Aug 30 2024

    Dr. Iyad Alnahhas interviews Dr. Linda Bi, Hia Ghosh and Ruchit Patel about their recent manuscript entitled: "Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4400 Tumors", published online in Neuro-Oncology in August 2024.

    More Information:
    https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noae164/7737688

    Show more Show less
    20 mins
  • FDG PET in PCNSL
    Aug 9 2024
    Dr. Iyad Alnahhas interviews Drs. Minyoung Oh and Hyungwoo Cho about their recent manuscript entitled: "Enhancing Prognostication and Treatment Response Evaluation in Primary CNS Lymphoma with 18F-FDG PET/CT", published online in Neuro-Oncology in August 2024. Link to manuscript
    Show more Show less
    10 mins
  • TMZ and MGMT in elderly GBM patients
    Jul 12 2024

    Dr. Jasmin Jo interviews Dr. Monika Hegi about her and her team's recent manuscript entitled: "No benefit from TMZ treatment in GB with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB patients", published online in Neuro-Oncology in (I will fill in through Libsyn)

    Show more Show less
    18 mins